Letters To The Editor

In reply: MAO inhibitors

Author and Disclosure Information

 

In Reply: Dr. Keller is correct, and we thank him for the clarification. We meant to say that selegiline is the only selective MAO-B inhibitor indicated for treating depression in the United States.

Next Article:

Premenopausal osteoporosis, an overlooked consequence of anorexia nervosa

Related Articles